A2 reumatologi og idrætsmedicin
About A2 reumatologi og idrætsmedicin
"A2 reumatologi og idrætsmedicin er reumatologer placeret i Holte. Har du smerter i led, sener eller muskler? Det kan dreje sig om gigt, idrætsskader eller overbelastning. Vi diagnosticerer og behandler sygdomme i bevægeapparatet. Ligeldes arbejder vi med PRP, ACT og stamcellebehandling af fx knæ, ankler, hofter, skuldre og albuer."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at A2 reumatologi og idrætsmedicin
During the past decade, A2 reumatologi og idrætsmedicin conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
2012-09-01
2017-07-01
Unknown status
700
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
2012-09-24
2018-07-13
Completed
498
An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)
2013-07-17
2023-12-31
Active, not recruiting
481
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy
2014-03-11
2019-01-09
Completed
1,225
Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
2014-06-01
2016-05-01
Terminated
265
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
2014-05-01
2019-05-06
Completed
209
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]
2015-07-20
2022-03-08
Completed
572
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at A2 reumatologi og idrætsmedicin
According to Clinical.Site data, the most researched conditions in "A2 reumatologi og idrætsmedicin" are
"Osteoarthritis, Knee" (3 trials). Many other conditions were trialed in "A2 reumatologi og idrætsmedicin" in a lesser frequency.
Clinical Trials Intervention Types at A2 reumatologi og idrætsmedicin
Most popular intervention types in "A2 reumatologi og idrætsmedicin" are "Device" (3 trials). Other intervention types were less common.
The name of intervention was led by "PAAG-OA" (2 trials), "Aquamid Reconstruction" (1 trials) and "Synvisc-One" (1 trials). Other intervention names were less common.
Clinical Trials Genders at A2 reumatologi og idrætsmedicin
The vast majority of trials in "A2 reumatologi og idrætsmedicin" are
3 trials for "All" genders.
Clinical Trials Status at A2 reumatologi og idrætsmedicin
Currently, there are NaN active trials in "A2 reumatologi og idrætsmedicin".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in A2 reumatologi og idrætsmedicin,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in A2 reumatologi og idrætsmedicin, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".